InterVenn Biosciences
Kaitlynn Moser is the VP of Clinical Development at InterVenn Biosciences. Previously, Kaitlynn was Senior Program Coordinator at Mayo Clinic.
Kaitlynn attended the University of North Florida.
This person is not in any offices
InterVenn Biosciences
1 followers
InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with applications from the Vista suite of solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression.